Herriot Tabuteau

Chief Executive Officer

Herriot Tabuteau (Chief Executive Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $23.9M of AXSM (139,414 sh across 3 lots, as filed), executed Jan 5.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$103.2M

shares × price, as filed

Last traded

Aug 6

Filed Aug 7

Median ADV $188.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $110.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

AXSM

Axsome Therapeutics, Inc. AXSM · 0 buys · 9 sells 9 filings

Recent filings

AXSMSALE Axsome Therapeutics, Inc. View filing → $10.5M
49,664 sh across 2 lots
Exec Aug 5
Filed Aug 7 · 7:00 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $11.9M
49,666 sh × $240.25
Exec Jul 1
Filed Jul 1 · 7:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $12.0M
49,670 sh × $241.01
Exec Jun 9
Filed Jun 9 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $6.0M
32,410 sh × $185.60
Exec Feb 2
Filed Feb 2 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $23.9M
139,414 sh across 3 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $11.6M
79,973 sh across 3 lots
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $21.8M
163,939 sh across 3 lots
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $5.4M
45,384 sh across 3 lots
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET More filings →